U
CNCE

UBS’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

UBS’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q3 		$3.28M Buy
260,172
+206,297
+383% +$2.6M ﹤0.01% 1845
2014
Q2 		$544K Buy
53,875
+42,041
+355% +$425K ﹤0.01% 3128
2014
Q1 		$159K Buy
+11,834
New +$159K ﹤0.01% 3877